DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc.
Stage unknownBoston, MABiotechnology
Facts
Financing history
1 rounds
- Jul 1, 2024Form D equity offering · $126M (form d sold) · 38 investorsFact SEC EDGAR Form D data sets (quarterly) · “Scorpion Therapeutics, Inc. filed Form D: $125,694,186 sold of $150,000,002, Biotechnology”
Investors on record
1 edges
- Vida Ventures Management board only, Arjun Goyal (strongly supported) Inference sec.gov
People
7 officers, 8 directors
- Adam Friedman Executive Officer/Director sec.gov
- Amanda Valentino Executive Officer sec.gov
- Andrew Fedder Executive Officer sec.gov
- Brian Piper Executive Officer sec.gov
- Darrin Stuart Executive Officer sec.gov
- Erica Jackson Executive Officer sec.gov
- Mark Chao Executive Officer sec.gov
- Oleg Nodelman Director Fact
- Otello Stampacchia Director Fact
- Shelley Chu Director Fact
- Jean-Francois Formela Director Fact
- Jeffrey Albers Director Fact
- Saurabh Saha Director Fact
- Arjun Goyal Director Inference
- Keith Flaherty Director Fact
Timeline
1
- Jul 16, 2024Scorpion Therapeutics, Inc. filed Form D: $125,694,186 sold of $150,000,002, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company
- Entity type: Corporation Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $126M Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $150M Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-07-01 Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 38 Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 1 Winthrop Square, Suite 400, Boston, MA, 02110 Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2020 Jul 16, 2024 Fact SEC EDGAR Form D data sets (quarterly)